Table 1.

Published case reports of aspergillus myocarditis 1955–2019.

Author	Year published	Number of Cases	Age: mean years (range)	% male / % female	% with positive blood cultures with Aspergillus	Case fatality rate	%pre-mortum diagnosis	Immunocompromising conditions (%)
Welsh et al. [22]	1955	1	18	100 / 0	0	100	0	Primary splenic neutropenia s/p splenectomy, corticosteroids
Fraumeni et al. [23]	1962	1	41	100 / 0	0	100	0	Hematologic malignancy, corticosteroids, chemotherapy
Burke et al. [20]	1970	1	51	100 / 0	100	100	100	corticosteroids, antimicrobials
Castleman et al. [21]	1971	1	33	100 / 0	0	100	0	corticosteroids, antimicrobials
Williams et al. [3]	1973	2	63 (60–66)	100 / 0	0	100	0	Chemotherapy, corticosteroids
Walsh et al. [25]	1980	6	30 (16–61)	0 / 100	0	100	16 (1/6)	Solid organ transplant, hematologic malignancy, corticosteroids
Ross et al. [10]	1985	1	31	100 / 0	0	100	0	Hematologic malignancy
Andersson et al. [11]	1986	3	34 (21–48)	33 / 66	0	100	0	Hematologic malignancy, chemotherapy
Rogers et al. [12]	1990	1	69	100 / 0	0	100	0	corticosteroids, broad-spectrum antimicrobials
Carrel et al. [26]	1991	1	68	100 / 0	0	100	0	corticosteroids
Cishek et al. [9]	1996	1	40	0 / 100	0	100	0%	corticosteroidsand 6-MP
Rouby et al. [24]	1998	1	75	100 / 0	0	100	0	corticosteroids, broad-spectrum antimicrobials
Xie et al. [8]	2005	11	41 (29–62)	100 / 0	0	100	9% (1/11)	AIDS with CD4 T-cells 10-121 cells/uL
Kemdem et al. [4]	2008	1	19	0 / 100	0	100	100%	corticosteroids, hematologic malignancy
Yano et al. [18]	2010	1	74	100 / 0	0	100	0%	None (tobacco use felt to be contributory)
Yoshino et al. [5]	2013	2	79 (76–81)	100 / 0	0	100	0	Hematologic malignancy, broad-spectrum antimicrobials
Dang-Tran et al. [7]	2014	1	68	100 / 0	100	100	100%	Solid-organ transplant, corticosteroids
Kim et al. [19]	2014	1	63	0 / 100	0	0	100	Aplastic anemia
Kupsky et al. [13]	2016	1	18	100 / 0	0	0	100%	Solid-organ transplant
Bullis et al.	2019	1	61	0 / 100	0	100	0	corticosteroids, Rituximab
Total	N/A	39	45 (16–81)	69 / 31	5	95	18